Trial · NCT07902193
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Time to extubation | From sugammadex administration to tracheal extubation, assessed up to 60 minutes | Time from sugammadex administration to tracheal extubation, in minutes and seconds. Time from end of surgery to extubation will also be recorded. |
| Secondary | Time from end of surgery to extubation | From the end of surgery to tracheal extubation, assessed up to 60 minutes | Time from the end of surgery to tracheal extubation, in seconds. |
| Secondary | Emergence agitation | On arrival in the post-anesthesia care unit (PACU) and at 5 and 10 minutes after arrival | Agitation will be assessed with the Richmond Agitation-Sedation Scale (RASS), which ranges from -5 (unarousable) to +4 (combative), with 0 indicating alert and calm; higher scores indicate greater agitation. RASS scores and the incidence of agitation, defined as a RASS score of +1 or higher, will be reported. |
| Secondary | Heart rate | Before the start of emergence; every minute for the first 10 minutes and at 15 minutes after the start of emergence; and at 1, 5 and 10 minutes after arrival in the post-anesthesia care unit (PACU) | Heart rate in beats per minute. |
| Secondary | Blood pressure | Before the start of emergence; every 5 minutes up to 15 minutes after the start of emergence; and at 1, 5 and 10 minutes after arrival in the post-anesthesia care unit (PACU) | Systolic, diastolic and mean arterial blood pressure in millimeters of mercury (mmHg).. |
| Secondary | Peripheral oxygen saturation (SpO2) | Before the start of emergence; every minute for the first 10 minutes and at 15 minutes after the start of emergence; and at 1, 5 and 10 minutes after arrival in the post-anesthesia care unit (PACU) | Peripheral oxygen saturation measured by pulse oximetry, in percent. |
| Secondary | Incidence of postoperative nausea and vomiting | From tracheal extubation to 10 minutes after arrival in the post-anesthesia care unit (PACU) | Number of participants with postoperative nausea and/or vomiting. |
| Secondary | Incidence of bradycardia | From sugammadex administration to 10 minutes after arrival in the post-anesthesia care unit (PACU) | Number of participants with bradycardia, defined as a heart rate below the age-specific lower limit or a decrease of more than 20% from baseline. |
| Secondary | Incidence of laryngospasm | From sugammadex administration to 10 minutes after arrival in the post-anesthesia care unit (PACU) | Number of participants with laryngospasm. |
| Secondary | Incidence of anaphylaxis | From sugammadex administration to 10 minutes after arrival in the post-anesthesia care unit (PACU) | Diagnosed according to the NIAID/FAAN clinical criteria and graded by Ring-Messmer. |
| Secondary | Incidence of skin rash | From sugammadex administration to 10 minutes after arrival in the post-anesthesia care unit (PACU) | Number of participants with skin rash. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07902193/registered